Published on Feb 13, 2015

Social worker Leora Lowenthal shares practical recommendations on how to live fully with cutaneous lymphoma.


Robert Knobler, MD of the Medical University of Vienna, Vienna, Austria talks about extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma (the particular varient being Sézary syndrome) at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. Extracorporeal photopheresis was invented in 1983 and became well known worldwide in 1987 when the first study was published in the New England Journal of Medicine. Prof. Knobler's role was to review the literature and the progress that has been done in the past 30 years in the use of this therapy. The literature of over 37 published papers (review articles and retrospective studies) have been reviewed and it has been found that the efficacy of this therapy, which was shown to be significant in inducing complete remission (CR) in refactory patients as well as patients who were responding to other therapies but not optimally, has been reproduced in over 1200 patients that were treated with this technology. The complete remission (CR) rates


Mrs. Cheryl Lewis-Blackwell had Sezary Syndrome #BUTGOD said be healed in Jesus Mighty name! Watch, comment, like and share her victory.
Subscribe to my channel for more BUTGOD TV Interviews as well as "Keep it Real Mondays" with my Co-Host Godz Poet.


Dr. Ajay Gopal discusses his optimism at the state of the treatment for Hodgkin Lymphoma, a disease that primarily affects young adults. For the newly diagnosed, he assures us that the standard therapies for the disease have been incredibly successful and most patients will be cured with the first treatment regimen. For those that are not, Dr. Gopal covers the range of options including autologous transplant and the expanding use of allogeneic transplant, made possible by the newly approved brentuximab vedotin (Adcetris).


At ASH 2015, Dr. Charles Herbaux discusses his abstract titled "Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC."
For more oncology news, education, and information, please visit


Published on Jan 4, 2016

Medical scientists have made major advances in treating different types of cancer in the past decade, but perhaps none more so than the blood cancer known as myeloma. WSJ's Ron Winslow explains on Lunch Break with Tanya Rivero. Photo: iStock/ChristianAnthony

Subscribe to the WSJ channel here:

More from the Wall Street Journal:

Follow WSJ on Facebook:
Follow WSJ on Google+:
Follow WSJ on Twitter:
Follow WSJ on Instagram:
Follow WSJ on Pinterest:


Published on Jun 17, 2015

Andy lost his first wife to multiple myeloma, then twelve years later, Andy himself was struck by the same disease.

Discover how every donation makes a difference at


Published on Oct 15, 2015

Multiple myeloma is a type of cancer that affects the plasma cells, which are white blood cells located in your bone marrow. This video briefly explains the causes, symptoms, and treatment.